Biotek-snakken — Marts 2022
-
Biotech Stocks Facing FDA Decision In April 2022 https://proinvestor.com/investornyt/801042/biotech-stocks-facing-fda-decision-in-april-2022
-
SynAct vil hente millioner på aktieemission https://proinvestor.com/investornyt/801047/synact-vil-hente-millioner-pa-aktieemission
-
SUTRO - er det ikke muligt at faldet forleden er udtryk for skepsis til FRa som target pga SORAYA og resultatet (andre mislykkede trials) samtidigt med at Bev gives skylden for kort PFS, som STR002 har et combo studie med. STRO-002 havde 70% prior Bev pts med i dose esc. og 63% prior Bev i dose exp. Har desværre ikke indsigt i Bev indvirken på PFS. Vi kan jo håbe på at det bare en dårligt undskyldning for at mirv ikke er super godt. idk ?
-
-
-
Carlsberg exit, Tesla stigning og bund i biotek? https://www.proinvestor.com/boards/102571
-
"Danske" IGM Bioscience laver flot aftale med Sanofi. 6 targets/$6B dev/reg milestone med 50/50 rev split på oncology targets. Oppe 70% https://kvgo.com/2022-oncology-conference/igm-biosciences-inc-feb
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind